Lycored has opened a new state-of-the-art processing facility in Branchburg, NJ for its carotenoids, vitamins, minerals, amino acids, and real food ingredients.
Lycored has opened a new state-of-the-art processing facility in Branchburg, NJ for its carotenoids, vitamins, minerals, amino acids, and real food ingredients. The new plant enables Lycored to maximize the purity, efficacy, and shelf-stability of its ingredients while exponentially increasing its output capacity. The facility also provides advanced capabilities for milling, blending, drying, and coating, with extensive opportunities for customization, as well as an application lab and production line that supports taste application development.
“Our Branchburg facility boasts formidable milling and blending proficiency with state-of-the-art technology,” says Shirley Cohen, CEO of Lycored, in a press release. “It allows us to optimize nutrient efficacy and bioavailability while providing innovative formulations perfectly tailored to our customers’ requirements. When you prioritize quality at every step of the journey, all health breaks loose.”
The FDA-registered, cGMP-compliant, and NSF-certified facility is allergen-free, with temperature and humidity-controlled environments. Lycored has also taken measures to dramatically reduce waste and preserve resources. These include reducing its reliance on energy and transportation, AI-powered planting and harvesting systems, as well as single-solvent tomato oleoresin extraction that reduces water usage.
“For more than a quarter of a century, we’ve been inspired to find new ways to make the most of natural nutrients for supplements and blends,” says Cohen. “We’ve learned a lot along the way, reinventing and streamlining countless processes to maximize wellness and minimize waste. We’re now excited to share the fruits of that journey in our brand-new, state-of-the-art custom production facility.”
A virtual tour of the new Branchburg, NJ facility can be taken here.
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.